| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 81% Accuracy percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, accuracy; subgroup values correspond to Supplemental Table S6 |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 83% Recall (class: benign) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, benign_sensitivity; subgroup values correspond to Supplemental Table S6 |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 83.1% Accuracy (variant type: missense) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, missense_accuracy; subgroup values correspond to Supplemental Table S6 |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 82% Accuracy (gene role: oncogene) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, oncogene_accuracy; subgroup values correspond to Supplemental Table S6 |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 88% Recall (class: oncogenic) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, oncogenic_sensitivity; subgroup values correspond to Supplemental Table S6 |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 0.87 Correlation (correlation type not stated) unitless · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Figure 2B, concordant variants only |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 77.7% Accuracy (variant type: truncating) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, truncating_accuracy; subgroup values correspond to Supplemental Table S6 |
|---|
| Configuration: OncoVI 2026 publication configuration | Protocol: OncoVI three-class assessment: Guideline SOP variants Dataset: Guideline SOP variants | 87.1% Accuracy (gene role: tumour suppressor) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOncoVI: Guideline SOP variants Not reported Aggregation: Not reported Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, Guideline SOP variants, tsg_accuracy; subgroup values correspond to Supplemental Table S6 |
|---|